Xtant Medical Holdings, Inc. - 8-K Filing
Xtant Medical reports Q3 2026 revenue of $24.3 million amid board-led strategic review process. (Items: 2.02 of this report (including Exhibit 99, 9.01 Financial Statements and Exhibits)
Tickers: $XTNT
Read the full article at SEC EDGAR
Part of the story VYCOR MEDICAL INC - 8-K Filing (3 articles)